Skip to the chapter
Sermorelin
The care notebook
Browse the notebook

Weigh · The care notebook

Pause when the claim outruns the record.

A clear-sounding offer may still leave its central question open.

A claim of approval needs the product named.

The FDA’s statement checked as of September 26, 2026 is that compounded medicines lack agency approval.

The agency does not verify their quality, effectiveness or safety before marketing.

If an offer says otherwise, ask which finished product the approval applies to. A statement about an ingredient’s history does not finish that check.

Read the FDA explanation of compounding

Evidence note

A product code is not an approval.

The FDA’s explanation as of September 26, 2026 makes clear that a product’s National Drug Code (NDC) provides no proof of approval.

An NDC is a code used in a drug directory.

Record it if provided, then ask for the actual product’s status.

Read the FDA explanation of drug codes

Check the care behind the offer.

As of September 26, 2026, federal law makes a valid prescription a requirement for obtaining prescription medicine.

The FDA includes a pharmacist available for questions and a state pharmacy licence among its checks for online pharmacies.

The FDA also cautions that a convincing pharmacy storefront can be fake.

Read the FDA’s online-pharmacy checks

Treat missing names or a conflicting record as questions to resolve. Keep your notes rather than trying to decide from the page’s polish.

Ask for something you can verify.

  • What record supports the approval claim?
  • Which pharmacy record matches the preparation?
  • Who decides whether to prescribe the medicine?
  • Can I get a clear answer before agreeing to pay?

The claim I could not verify: